Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Healing Chronic Complex Wounds with Perinatal Tissue Allografts with Jason Matuszewski and Andrew Van Vurst BioStem Technologies TRANSCRIPT
Download PDFSep 29, 2022
Jason Matuszewski, Chief Executive Officer and Chairman of the Board, and Andrew Van Vurst, Chief Operating Officer of BioStem Technologies have a vision to change the paradigm on the use of perinatal tissue for advanced wound care. Their initial target is complex wounds in the lower extremity region, specifically...
Sep 29, 2022
Jason Matuszewski, Chief Executive Officer and Chairman of the Board, and Andrew Van Vurst, Chief Operating Officer of BioStem Technologies have a vision to change the paradigm on the use of perinatal tissue for advanced wound care. Their initial target is complex wounds in the lower extremity region, specifically...
Improving Cognitive and Independent Function of Alzheimer’s Patients with Sharon L. Rogers AmyriAD Therapeutics TRANSCRIPT
Download PDFSep 28, 2022
Sharon L. Rogers Ph.D. is the CEO of AmyriAD Therapeutics and has a deep understanding of the development of drugs to address the impact of Alzheimer's disease. Currently, the most common treatment is Aricept which Sharon developed and brought to market in 1996. Based on recent research, it does not appear that disease...
Sep 28, 2022
Sharon L. Rogers Ph.D. is the CEO of AmyriAD Therapeutics and has a deep understanding of the development of drugs to address the impact of Alzheimer's disease. Currently, the most common treatment is Aricept which Sharon developed and brought to market in 1996. Based on recent research, it does not appear that disease...
Targeting and Deploying Optimum Radiopharmaceuticals to Treat Cancer with Jack Hoppin and John Babich Ratio Therapeutics TRANSCRIPT
Download PDFSep 27, 2022
Jack Hoppin Ph.D. Chief Executive Officer and John Babich Ph.D., President and Chief Scientific Officer, and Co-Founders of Ratio Therapeutics aim to develop and produce best-in-class radiopharmaceuticals. Harnessing the power of radiation by making it into an injectable drug, Ratio is creating a way to find tumor cells...